Organigram Holdings reports first-quarter 2025 earnings, meeting market expectations. The company navigates the challenges in the broader cannabis indus
Organigram Holdings Inc. (OGI) announced impressive earnings for the latest quarter, attributing the growth to robust brand performance and effective market exe
PR NewswireTORONTO, April 11, 2025
Six nominees stand for election to the Board of Directors: Rusty Lewis, Chuck Myers,Asha Daniere, Pasquale T. (Pat) Deo
TORONTO — Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is proud to announce its off…
Organigram Holdings Inc. (”Organigram” or the ”Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and speci
Net Revenue: Increased 17% to $42.7 million compared to Q1 of last year.International Sales: Grew 2.3% year over year to $3.3 million.Adjusted Gross Margin: In
Organigram Holdings Inc. (NASDAQ:OGI) Q1 2025 Earnings Conference Call February 11, 2025 8:00 AM ETCompany ParticipantsMax Schwartz - Director of IRBeena...
17% growth in net revenue to $42.7 million year-over-year $2.3 million growth in international sales year-over-year Adjusted EBITDA1 of $1.4 million versus $0.1…
TORONTO — Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed pr…
Organigram Holdings Inc. (NASDAQ:OGI) Q3 2024 Earnings Conference Call December 18, 2024 8:00 AM ETCompany ParticipantsMax Schwartz - Director of IRBeena...
Organigram's Q4 sales hit $31.22 million, boosted by recreational and international growth, with adjusted gross margin improving to 37% of net revenue.
Fiscal 2024 net revenue of $159.8 million 17.6% year-over-year growth in Organigram’s recreational shipped sales in Fiscal 2024 Q4 Fiscal 2024 adjusted gross ma…